D
Dorvexadr
Back to home
Terms and Conditions

Last updated: January 2024

Introduction

Welcome to Dorvexadr. These terms and conditions outline the rules and regulations for the use of Dorvexadr's Website, located at dorvexadr.com. By accessing this website, we assume you accept these terms and conditions.

Use of Service

By using our services, you agree to:

  • Use the website only for legal and educational purposes
  • Not interfere with the website's operation
  • Not transmit malicious or harmful material
  • Respect intellectual property rights

Educational Purpose

Dorvexadr is an educational platform that provides general information about financial topics. All content is presented for educational and informational purposes only. We do not provide personalized investment advice or specific investment recommendations.

Limitations

Liability limitations:

  • We do not guarantee complete accuracy of all information
  • We are not responsible for decisions based on our content
  • Past returns do not guarantee future results
  • All investments carry inherent risks

Modifications

We reserve the right to revise these terms at any time. By continuing to use this website after changes are posted, you agree to be bound by the revised version.

Applicable Law

These terms are governed by the laws of Argentina. Any dispute related to these terms shall be subject to the exclusive jurisdiction of the courts of the Autonomous City of Buenos Aires, Argentina.

For questions about these terms, contact us at info@dorvexadr.com

D
Dorvexadr

Financial information educational platform for Argentina

Av. Corrientes 1234, C1043AAZ, Autonomous City of Buenos Aires, Argentina
info@dorvexadr.com
+54 11 1234-5678

Registration: CUIT 20-12345678-9

Tax ID: 20-12345678-9

Educational License: LE-2024-001

Jurisdiction: Autonomous City of Buenos Aires

Year of Incorporation: 2024

Educational materials, not investment advice

Potential returns considering risks

Historical performance does not guarantee future results

© 2024 Dorvexadr. All rights reserved.